Analysts Set Masimo Co. (NASDAQ:MASI) PT at $190.29

Shares of Masimo Co. (NASDAQ:MASIGet Rating) have earned an average rating of “Moderate Buy” from the nine brokerages that are currently covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $190.29.

Several equities analysts have recently issued reports on MASI shares. Piper Sandler reduced their target price on Masimo from $150.00 to $135.00 and set a “neutral” rating for the company in a report on Wednesday, November 9th. Needham & Company LLC upped their target price on Masimo from $163.00 to $179.00 and gave the company a “buy” rating in a report on Wednesday, August 10th. Wolfe Research raised Masimo from a “peer perform” rating to an “outperform” rating and set a $165.00 price objective for the company in a report on Thursday, September 15th. StockNews.com began coverage on Masimo in a report on Wednesday, October 12th. They set a “hold” rating for the company. Finally, Jefferies Financial Group initiated coverage on Masimo in a report on Wednesday, October 12th. They set a “buy” rating and a $180.00 price objective for the company.

Insider Buying and Selling

In other Masimo news, CEO Joe E. Kiani acquired 7,784 shares of the stock in a transaction that occurred on Friday, November 11th. The shares were bought at an average price of $129.27 per share, for a total transaction of $1,006,237.68. Following the completion of the transaction, the chief executive officer now owns 7,784 shares of the company’s stock, valued at approximately $1,006,237.68. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other news, CEO Joe E. Kiani purchased 7,784 shares of the stock in a transaction on Friday, November 11th. The shares were acquired at an average price of $129.27 per share, for a total transaction of $1,006,237.68. Following the completion of the transaction, the chief executive officer now directly owns 7,784 shares of the company’s stock, valued at approximately $1,006,237.68. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Joe E. Kiani purchased 31,994 shares of the stock in a transaction on Monday, November 14th. The shares were purchased at an average price of $123.99 per share, for a total transaction of $3,966,936.06. Following the transaction, the chief executive officer now directly owns 39,778 shares of the company’s stock, valued at $4,932,074.22. The disclosure for this purchase can be found here. 9.70% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Masimo

A number of large investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its position in Masimo by 1.5% during the first quarter. Vanguard Group Inc. now owns 4,775,660 shares of the medical equipment provider’s stock valued at $695,050,000 after purchasing an additional 71,918 shares in the last quarter. Politan Capital Management LP purchased a new stake in Masimo during the third quarter valued at about $656,234,000. FMR LLC grew its stake in shares of Masimo by 1.7% during the second quarter. FMR LLC now owns 2,104,939 shares of the medical equipment provider’s stock valued at $275,052,000 after buying an additional 35,438 shares during the last quarter. Nomura Holdings Inc. bought a new position in shares of Masimo during the second quarter valued at about $242,537,000. Finally, State Street Corp grew its stake in shares of Masimo by 1.6% during the first quarter. State Street Corp now owns 1,730,991 shares of the medical equipment provider’s stock valued at $251,928,000 after buying an additional 27,261 shares during the last quarter. Hedge funds and other institutional investors own 93.31% of the company’s stock.

Masimo Stock Performance

MASI stock opened at $143.02 on Friday. The firm has a market cap of $7.52 billion, a PE ratio of 47.36 and a beta of 0.87. The company has a quick ratio of 1.28, a current ratio of 2.12 and a debt-to-equity ratio of 0.76. The business has a 50 day moving average of $136.18 and a 200-day moving average of $139.59. Masimo has a 12-month low of $108.89 and a 12-month high of $299.78.

Masimo Company Profile

(Get Rating)

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.

Recommended Stories

Analyst Recommendations for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.